Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegilidine fumarate for postoperative analgesia after lower limb fracture surgery
ChiCTR2600117475Phase 2Recruiting
- Sponsor
- Tianjin First Central Hospital
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tegileridine in postoperative pain (3 arms), sponsored by Tianjin First Central Hospital. Primary endpoints: Numerical Rating Scale (NRS) pain scores at rest and during activity and Percentage of subjects using rescue analgesics. Started Jan 2026; status: recruiting.
02
Drugs
tegileridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600117475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117475.